Adding Bevacizumab to Chemo May Prolong Survival

May 8, 2017 8:58 pm

Adding bevacizumab to platinum-based chemotherapy may improve survival among women with recurrent ovarian cancer, according to a study published in Lancet Oncology.1

Bevacizumab is emerging as an effective strategy as a first-line or maintenance therapy for recurrent ovarian … Read more